论文部分内容阅读
AI307制剂是一种新的化合物,由七个分子的5,7二溴8羟基喹啉(5,7-dibrom-8-hydroxy-quinoline)和一个分子的5,7二溴8苯(甲)酸基喹哪啶(5,7-dibrom-8-benzoyloxy-quinaldine)混合组成。这两种化合物在抗阿米巴和抗细菌的作用上具有极大限度的协同性。作者用AI307治疗92例肠道阿米巴病患者。年龄自5岁半至52岁共有儿童37名成人55名。在这些病例中
The AI307 preparation is a novel compound consisting of seven molecules of 5,7-dibrom-8-hydroxy-quinoline and one molecule of 5,7-dibromo-8benzene (A) 5,7-dibrom-8-benzoyloxy-quinaldine. Both compounds have a great deal of synergy with anti-amoebic and anti-bacterial effects. The authors treated 92 patients with intestinal amoebiasis with AI307. There are 37 adults and 55 children aged from 5 years old to 52 years old. In these cases